Chapter 26. Therapeutic Strategies in the Treatment of AIDS
- 1 January 1988
- book chapter
- Published by Elsevier
- Vol. 23, 253-263
- https://doi.org/10.1016/s0065-7743(08)60854-4
Abstract
No abstract availableThis publication has 88 references indexed in Scilit:
- Azidothymidine in the Treatment of AIDSNew England Journal of Medicine, 1988
- The Toxicity of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related ComplexNew England Journal of Medicine, 1987
- The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related ComplexNew England Journal of Medicine, 1987
- Selective inhibition of human immunodeficiency virus (HIV) by 3′-Azido-2′,3′-dideoxyguanosine invitroBiochemical and Biophysical Research Communications, 1987
- The 2′,3′-dideoxyriboside of 2,6-diaminopurine and its 2′,3′-didehydro derivative inhibit the deamination of 2′,3′-dideoxyadenosine, an inhibitor of human immunodeficiency virus (HIV) replicationBiochemical and Biophysical Research Communications, 1987
- Development of Antiretroviral Therapy for the Acquired Immunodeficiency Syndrome and Related DisordersNew England Journal of Medicine, 1987
- Significant Changes in HIV Antigen Level in the Serum of Patients Treated with AzidothymidineNew England Journal of Medicine, 1986
- Potent and selective anti-HTLV-IIILAV activity of 2′,3′-dideoxycytidinene, the 2′,3′-unsaturated derivative of 2′,3′-dideoxycytidineBiochemical and Biophysical Research Communications, 1986
- T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAVNature, 1984
- The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirusNature, 1984